What changed
$SNX — AVOID 📊 | 6 MONTHS THESIS
🎯 FQ2 FY2026 (ends May) | reported Jun 25 | Rev $17.2B | EPS $4.70 vs $3.92 🟢 | Margin 2.9%
💡 Consensus expected $3.92 EPS; the $4.70 beat suggests cost controls or mix improvement. However, the market may be over‑extrapolating a single quarter—negative OCF and thin margins argue the high‑teens P/E needed for the base case won't sustain. The consensus gap is positive, but it's already well‑known post‑report.
📉 Reward/risk: 1.09:1
🏢 Business Quality: 3/10
📊 Valuation: fair
🔮 Catalyst: FQ2 FY2026 earnings report (Jun 25)
💰 Entry: $262.79, stop $151.83, target $383.68
⚖️ Avoid: a 20% EPS beat isn't enough to compensate for negative cash flow and a 1.0:1 reward/risk setup; wait for real cash‑flow improvement before committing capital.
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/SNX0627